Oppenheimer Asset Management’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
Other funds holding TDOC
AIM
NAMA
SOMRS
KA
Oppenheimer Asset Management's TDOC Position: Q2 2022 in Review
Oppenheimer Asset Management sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 26,043 shares — an estimated $1.88M sold.
Oppenheimer Asset Management first reported a position in TDOC in Q2 2017 and held it in 19 quarters. The position peaked at $10.6M in Q3 2020. 551 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.
- Oppenheimer Asset Management reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
- Oppenheimer Asset Management sold 26,043 Teladoc Health shares in Q2 2022, an estimated $1.88M.
- Oppenheimer Asset Management first reported a position in Teladoc Health in Q2 2017 and held it in 19 quarters.
- Oppenheimer Asset Management's Teladoc Health position peaked at $10.6M in Q3 2020.
- 551 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.
Based on Oppenheimer Asset Management's 13F filing for Q2 2022, filed 8 Aug 2022.